Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
2.825
-0.275 (-8.87%)
Dec 3, 2024, 1:50 PM EST - Market open
Sunshine Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 3, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 6 | 7 | 14 | 30 | 5 | 0 | |
| Market Cap Growth | -56.60% | -51.77% | -52.26% | 480.17% | 1941.74% | -79.87% | |
| Enterprise Value | -5 | -11 | -26 | 32 | 6 | 1 | |
| Last Close Price | 3.10 | 543.00 | 1280.00 | 23380.00 | 6280.00 | 3600.00 | |
| PS Ratio | 0.02 | 0.29 | 3.33 | 132.55 | 73.08 | 12.10 | |
| PB Ratio | 0.25 | 0.33 | 0.67 | 143.04 | -5.47 | -0.35 | |
| P/TBV Ratio | 0.16 | 0.35 | 0.69 | 271.15 | - | - | |
| EV/Sales Ratio | - | - | - | 137.98 | 81.76 | 47.12 | |
| Debt / Equity Ratio | 0.02 | 0.03 | 0.04 | 8.98 | -2.00 | -0.97 | |
| Asset Turnover | 1.14 | 0.85 | 0.28 | 0.14 | 0.12 | 0.03 | |
| Inventory Turnover | 3.18 | 3.49 | 1.56 | 1.82 | 1.30 | - | |
| Quick Ratio | 3.41 | 3.39 | 3.42 | 22.59 | 0.95 | 0.06 | |
| Current Ratio | 5.74 | 4.48 | 3.94 | 24.07 | 0.98 | 0.08 | |
| Return on Equity (ROE) | -17.98% | -21.04% | -244.92% | - | - | - | |
| Return on Assets (ROA) | -10.75% | -10.57% | -34.48% | -93.90% | -63.05% | -64.44% | |
| Return on Capital (ROIC) | -12.86% | -13.52% | -44.25% | -99.36% | -76.84% | -91.45% | |
| Earnings Yield | -74.28% | -64.63% | -185.03% | -41.08% | -53.35% | -649.57% | |
| FCF Yield | -228.26% | -127.05% | -37.65% | -6.04% | -12.62% | -194.31% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.